Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: Perspectives for public health

[1]  T. Puthanakit,et al.  Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019 , 2020, PloS one.

[2]  M. Rodgers,et al.  A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay , 2020, Journal of Clinical Virology.

[3]  Xin Lu,et al.  Changes in serum virus-specific IgM/IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test (RPNAT) , 2020, Annals of medicine.

[4]  J. Mingorance,et al.  Evaluation of three immunochromatographic tests for rapid detection of antibodies against SARS-CoV-2 , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  J. Yombi,et al.  Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID‐19 patients , 2020, Journal of medical virology.

[6]  P. Kelleher,et al.  High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. , 2020, Journal of the American Society of Nephrology : JASN.

[7]  P. Zhou,et al.  Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak , 2020, Virologica Sinica.

[8]  N. Takayanagi,et al.  High incidence of false-positive results of IgG antibody against SARS-CoV-2 with rapid immunochromatographic antibody test due to human common cold coronavirus infection , 2020, Respiratory Medicine Case Reports.

[9]  R. Pontarolo,et al.  Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19 , 2020, American Journal of Infection Control.

[10]  G. Ippolito,et al.  Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test , 2020, Journal of Clinical Virology.

[11]  Jing Huang,et al.  Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China , 2020, American Journal of Kidney Diseases.

[12]  Devy M. Emperador,et al.  Antibody tests for identification of current and past infection with SARS‐CoV‐2 , 2020, The Cochrane database of systematic reviews.

[13]  A. Kouatchet,et al.  Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech) , 2020, Journal of Clinical Virology.

[14]  S. Poddar,et al.  Changing epidemiology of SARS-CoV in the context of COVID-19 pandemic , 2020, Journal of preventive medicine and hygiene.

[15]  C. Napoli,et al.  Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy , 2020, International journal of environmental research and public health.

[16]  Mario Plebani,et al.  Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics , 2020, Clinical chemistry and laboratory medicine.

[17]  B. Kodali,et al.  Adaptation of labor and delivery to COVID-19. , 2020, American Journal of Disaster Medicine.

[18]  Yaping Tian,et al.  Establishing a high sensitivity detection method for SARS-CoV-2 IgM/IgG and developing a clinical application of this method , 2020, Emerging microbes & infections.

[19]  S. Porru,et al.  Linee guida per la sorveglianza sanitaria dei lavoratori della sanità esposti a rischio biologico , 2005 .